<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0255562</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5985</journal-id>
<journal-id journal-id-type="nlm-ta">N Engl J Med</journal-id>
<journal-id journal-id-type="iso-abbrev">N. Engl. J. Med.</journal-id>
<journal-title-group>
<journal-title>The New England journal of medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0028-4793</issn>
<issn pub-type="epub">1533-4406</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30970187</article-id>
<article-id pub-id-type="pmc">6596298</article-id>
<article-id pub-id-type="doi">10.1056/NEJMoa1706594</article-id>
<article-id pub-id-type="manuscript">NIHMS1529624</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular Genetic Anatomy and Risk Profile of Hirschsprung’s Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tilghman</surname>
<given-names>Joseph M.</given-names>
</name>
<degrees>B.S.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ling</surname>
<given-names>Albee Y.</given-names>
</name>
<degrees>B.S.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Turner</surname>
<given-names>Tychele N.</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sosa</surname>
<given-names>Maria X.</given-names>
</name>
<degrees>M.S.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krumm</surname>
<given-names>Niklas</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chatterjee</surname>
<given-names>Sumantra</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kapoor</surname>
<given-names>Ashish</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coe</surname>
<given-names>Bradley P.</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nguyen</surname>
<given-names>Khanh-Dung H.</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gupta</surname>
<given-names>Namrata</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gabriel</surname>
<given-names>Stacey</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eichler</surname>
<given-names>Evan E.</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berrios</surname>
<given-names>Courtney</given-names>
</name>
<degrees>M.S.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chakravarti</surname>
<given-names>Aravinda</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<aff id="A1">Center for Complex Disease Genomics, Johns Hopkins University School of Medicine, Baltimore (J.M.T., A.Y.L., T.N.T., M.X.S., S.C., A.K., K.-D.H.N., C.B., A.C.); the Department of Genome Sciences, University of Washington School of Medicine (T.N.T., N.K., A.K., B.P.C., E.E.E.), and the Howard Hughes Medical Institute, University of Washington (E.E.E.) — both in Seattle; and Broad Institute of Harvard and MIT, Cambridge, MA (K.-D.H.N., N.G., S.G.).</aff>
</contrib-group>
<author-notes>
<corresp id="CR1">Address reprint requests to Dr. Chakravarti at the Center for Human Genetics and Genomics, New York University School of Medicine, 435 E. 30th St., Rm. 802/3, New York, NY 10016, or at <email>aravinda.chakravarti@nyulangone.org</email>.</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>11</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>10</month>
<year>2019</year>
</pub-date>
<volume>380</volume>
<issue>15</issue>
<fpage>1421</fpage>
<lpage>1432</lpage>
<!--elocation-id from pubmed: 10.1056/NEJMoa1706594-->
<abstract id="ABS1">
<sec id="S1">
<title>BACKGROUND</title>
<p id="P1">Hirschsprung’s disease, or congenital aganglionosis, is a developmental disorder of the enteric nervous system and is the most common cause of intestinal obstruction in neonates and infants. The disease has more than 80% heritability, including significant associations with rare and common sequence variants in genes related to the enteric nervous system, as well as with monogenic and chromosomal syndromes.</p>
</sec>
<sec id="S2">
<title>METHODS</title>
<p id="P2">We genotyped and exome-sequenced samples from 190 patients with Hirschsprung’s disease to quantify the genetic burden in patients with this condition. DNA sequence variants, large copy-number variants, and karyotype variants in probands were considered to be pathogenic when they were significantly associated with Hirschsprung’s disease or another neurodevelopmental disorder. Novel genes were confirmed by functional studies in the mouse and human embryonic gut and in zebrafish embryos.</p>
</sec>
<sec id="S3">
<title>RESULTS</title>
<p id="P3">The presence of five or more variants in four noncoding elements defined a widespread risk of Hirschsprung’s disease (48.4% of patients and 17.1% of controls; odds ratio, 4.54; 95% confidence interval [CI], 3.19 to 6.46). Rare coding variants in 24 genes that play roles in enteric neural-crest cell fate, 7 of which were novel, were also common (34.7% of patients and 5.0% of controls) and conferred a much greater risk than noncoding variants (odds ratio, 10.02; 95% CI, 6.45 to 15.58). Large copy-number variants, which were present in fewer patients (11.4%, as compared with 0.2% of controls), conferred the highest risk (odds ratio, 63.07; 95% CI, 36.75 to 108.25). At least one identifiable genetic risk factor was found in 72.1% of the patients, and at least 48.4% of patients had a structural or regulatory deficiency in the gene encoding receptor tyrosine kinase (<italic>RET</italic>). For individual patients, the estimated risk of Hirschsprung’s disease ranged from 5.33 cases per 100,000 live births (approximately 1 per 18,800) to 8.38 per 1000 live births (approximately 1 per 120).</p>
</sec>
<sec id="S4">
<title>CONCLUSIONS</title>
<p id="P4">Among the patients in our study, Hirschsprung’s disease arose from common noncoding variants, rare coding variants, and copy-number variants affecting genes involved in enteric neural-crest cell fate that exacerbate the widespread genetic susceptibility associated with <italic>RET</italic>. For individual patients, the genotype-specific odds ratios varied by a factor of approximately 67, which provides a basis for risk stratification and genetic counseling. (Funded by the National Institutes of Health.)</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>